Israel’s Rosetta Genomics has announced that its RosettaGX Reveal diagnostic test for thyroid cancer is now approved for use in all 50 US states.
http://rosettagx.com/files/press-releases/14562724557a5bb93300ad4859286115fb6a48c232.pdf
Diagnosing thyroid cancer
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.